LV dysfunction and pulmunary congestion in dialysis patients F. - - PowerPoint PPT Presentation

lv dysfunction and pulmunary congestion in dialysis
SMART_READER_LITE
LIVE PREVIEW

LV dysfunction and pulmunary congestion in dialysis patients F. - - PowerPoint PPT Presentation

Cagliari 30 aprile 3 maggio 2011 LV dysfunction and pulmunary congestion in dialysis patients F. Mallamaci Death rate (1 year) Death rate (1 year) % % % % 100 100 100 100 ESRD ESRD SIN registry SIN registry X 5 10 10 10 10


slide-1
SLIDE 1

LV dysfunction and pulmunary congestion in dialysis patients

Cagliari 30 aprile 3 maggio 2011

  • F. Mallamaci
slide-2
SLIDE 2

X 350

X 5

Courtesy of Massimo Cirillo 2006 Courtesy of Massimo Cirillo 2006

ISTAT ISTAT

Death rate Death rate (1 year)

(1 year)

% %

100 100 10 10 1 1 0.1 0.1 0.01 0.01 <15 15 <15 15-

  • 24 25

24 25-

  • 44 45

44 45-

  • 64 65

64 65-

  • 74 >74

74 >74 Age (years) Age (years) % % 100 100 10 10 1 1 0.1 0.1 0.01 0.01

ESRD ESRD SIN registry SIN registry

slide-3
SLIDE 3

Cardiac disease Cardiac disease in

in ESRD

ESRD

70% LVH 70% LVH

LV systolic dysfunction: LV systolic dysfunction: ∼ ∼40% 40% LV diastolic dysfunction: LV diastolic dysfunction: ∼ ∼100% 100% Why the risk of cardiac disease is so high in Why the risk of cardiac disease is so high in ESRD? ESRD? How this risk is generated? How this risk is generated?

slide-4
SLIDE 4

Relative Risk Relative Risk (fully independent) (fully independent)

4 4 3 3 2 2 1 1

GFR GFR

ml/min ml/min

120 120 60 60

1.4 2.0 2.0 2.8 2.8 3.4 3.4 1.0 1.0 60< 60< 45 45 3aCKD 3aCKD 30 30 3bCKD 3bCKD 15 15 4CKD 4CKD 5CKD 5CKD

Go AS, New Engl J Med. 351: 1296; 2004 Go AS, New Engl J Med. 351: 1296; 2004 1.120.295 individuals, follow up 2.8 years 1.120.295 individuals, follow up 2.8 years REFERENCE REFERENCE

REFERENCE REFERENCE REFERENCE Emerging risk factors

Inflammation Inflammation ⇑ ⇑ Sympathetic activity Sympathetic activity ⇑ ⇑ Asymmetric Dimethyl Arginine (ADMA) Asymmetric Dimethyl Arginine (ADMA)

Old age Old age

The GFR captures the The GFR captures the prognostic value of these prognostic value of these non non-

  • Framingham risk

Framingham risk factors factors

Volume expansion Volume expansion

⇑ ⇑Cholesterol Cholesterol ⇑ ⇑ Glucose/Diabetes Glucose/Diabetes

risk factors peculiar to CKD risk factors peculiar to CKD

Anemia Anemia ⇑ ⇑P P ⇑ ⇑PTH PTH

Why volume expansion is so Why volume expansion is so difficult to control in the difficult to control in the modern dialysis era when UF modern dialysis era when UF technology allows precise and technology allows precise and effective volume removal effective volume removal profiling? profiling?

Simple measurements of TBW or ECV Simple measurements of TBW or ECV insufficient or even misleading in HD pts insufficient or even misleading in HD pts

slide-5
SLIDE 5

Extracellular Volume (sodium space) Extracellular Volume (sodium space) ∼ ∼16 16-

  • 18 L

18 L Blood Volume Blood Volume ( (~30% extracellular volume) ~30% extracellular volume) 5.6 5.6L L

located in the vascular space , encompassing located in the vascular space , encompassing heart, aorta down to capillary bed and back to heart, aorta down to capillary bed and back to the venous system the venous system . .

LV filling Pressure LV filling Pressure

8 8-

  • 10 mmHg

10 mmHg

Cardiac Extracellular Fluids Cardiac Extracellular Fluids function Volume function Volume

The fundamental parameter for defining the loading conditions of The fundamental parameter for defining the loading conditions of the CV system, i.e. the relationship between circulating volume the CV system, i.e. the relationship between circulating volume and and CV function. CV function.

  • variable space, depending on vascular tone

variable space, depending on vascular tone and compliance and compliance

In reality fluids volume is In reality fluids volume is

slide-6
SLIDE 6

Capillary Pressure at Capillary Pressure at alveolar level alveolar level

Atrial Pressure Atrial Pressure LV Diastolic (filling) LV Diastolic (filling) Pressure Pressure

  • .. Is there any reliable

.. Is there any reliable proxy of LV filling pressure ? proxy of LV filling pressure ?

Capillary Wedge Pressure Capillary Wedge Pressure a very reliable indicator of a very reliable indicator of LV filling pressure LV filling pressure

However highly reliable, However highly reliable, this is an invasive this is an invasive technique and therefore it technique and therefore it is employed in the acute is employed in the acute setting only. setting only.

which depends on 2 components: which depends on 2 components: 1) volume 2) LV function component . 1) volume 2) LV function component . Therefore it reflects the loading conditions of the Therefore it reflects the loading conditions of the LV at a given Blood Volume LV at a given Blood Volume

slide-7
SLIDE 7

Capillary Pressure at Capillary Pressure at alveolar level alveolar level Pulmonary Water Pulmonary Water Pulmonary edema Pulmonary edema Lung comets Lung comets ! the number of lung comets is strictly ! the number of lung comets is strictly proportional to lung water proportional to lung water

Lung water

CHEST CHEST

127:1690, 2005 127:1690, 2005

slide-8
SLIDE 8

Severe lung Severe lung congestion congestion Moderate lung Moderate lung congestion congestion <14 14 <14 14-

  • 30 >30

30 >30 Lung Comets number Lung Comets number Prevalence Prevalence (%) (%) 50 50 40 40 30 30 20 20 10 10 35% 35% 28% 28% Hypo Normal Hyper Hypo Normal Hyper Hydration Status by BIA Hydration Status by BIA Lung Comets Lung Comets (n) (n) 60 60 50 50 40 40 30 30 20 20 10 10 17 17 20 20 15 15

Predialysis Predialysis

Detection of pulmonary congestion by chest ultrasound (US) in dialysis patients. Mallamaci F, Benedetto A, Tripepi R, Rastelli S, Castellino P, Tripepi G, Picano E, Zoccali C 3;586; 2010

Median # of Median # of comets: 18 comets: 18

Useful in Dialysis patients? Useful in Dialysis patients? an inclusive study: All but 3 patients of a large dialysis unit an inclusive study: All but 3 patients of a large dialysis unit (n=78). (n=78). Lung comets, BIA, echocardiography measured pre and post Lung comets, BIA, echocardiography measured pre and post-

  • dialysis

dialysis

The lack of association with hydration The lack of association with hydration status indicates that in this population LV status indicates that in this population LV dysfunction is the fundamental driver of dysfunction is the fundamental driver of lung congestion in ESRD. lung congestion in ESRD.

slide-9
SLIDE 9

Pulmonary Pressure Pulmonary Pressure (mmHg) (mmHg)

Left atrial Volume Left atrial Volume

r=0.33, P=0.002

70 60 50 40 30 20 10 200 150 100 50

Lung comets (n)

r=0.39, P<0.001

30 25 20 15 10 5

(mL/m2.7)

200 150 100 50

Lung comets (n)

r=-0.73, P<0.001

80 70 60 50 40 30 20 10 200 150 100 50

Lung comets (n)

Detection of pulmonary congestion by chest ultrasound (US) in dialysis patients. Mallamaci F, Benedetto A, Tripepi R, Rastelli S, Castellino P, Tripepi G, Picano E, Zoccali C 3:586 ; 2010

LV Ejection LV Ejection Fraction (%) Fraction (%)

slide-10
SLIDE 10

Detection of pulmonary congestion by chest ultrasound (US) in dialysis patients. Mallamaci F, Benedetto A, Tripepi R, Rastelli S, Castellino P, Tripepi G, Picano E, Zoccali C 3:586; 2010 Severe lung Severe lung congestion congestion Moderate lung Moderate lung congestion congestion <14 14 <14 14-

  • 30 >30

30 >30 Lung Comets number Lung Comets number Prevalence Prevalence (%) (%) 50 50 40 40 30 30 20 20 10 10 33% 33% 30% 30%

Postdialysis Postdialysis Median # of Median # of comets: 10 comets: 10

slide-11
SLIDE 11

Pulmonary Pressure Pulmonary Pressure (mmHg) (mmHg)

Left atrial Volume Left atrial Volume

r=0.32, P=0.006

70 60 50 40 30 20 10 200 150 100 50

Lung comets (n)

30 25 20 15 10 5

(mL/m2.7)

200 150 100 50

Lung comets (n)

r=-0.64, P<0.001

80 70 60 50 40 30 20 10 200 150 100 50

Lung comets (n)

Detection of pulmonary congestion by chest ultrasound (US) in dialysis patients. Mallamaci F, Benedetto A, Tripepi R, Rastelli S, Castellino P, Tripepi G, Picano E, Zoccali C 3:586 ; 2010

LV Ejection LV Ejection Fraction (%) Fraction (%)

r=0.30, P=0.01

slide-12
SLIDE 12

200 180 160 140 120 100 80 60 40 20

Pre-dialysis lung comets (n)

140 120 100 80 60 40 20

  • 20

Lung comets changes (n)

r=0.75 P<0.001

Detection of pulmonary congestion by chest ultrasound (US) in dialysis patients. Mallamaci F, Benedetto A, Tripepi R, Rastelli S, Castellino P, Tripepi G, Picano E, Zoccali C 3:586; 2010

Lung comets changes are directly associate to the number of Lung comets changes are directly associate to the number of comets before the dialysis session comets before the dialysis session .. ..

slide-13
SLIDE 13

Peritoneal Dialysis Peritoneal Dialysis Volume expansion : often a major problem Volume expansion : often a major problem Hemodialysis Hemodialysis Peritoneal Dialysis Peritoneal Dialysis

n=201 n=201 n=51 n=51

Systolic BP Systolic BP mmHg mmHg 180 180 140 140 100 100 Left Atrial volume Left Atrial volume ml ml 80 80 60 60 40 40 20 20 90 90 70 70 50 50 30 30

LVH (%) 62% 62% 86% 86% P <0.001

PD patients obviously volume PD patients obviously volume expanded. expanded. A change in local clinical policies A change in local clinical policies clearly needed clearly needed

60% 60%

Systolic BP Systolic BP mmHg mmHg 180 180 140 140 100 100 90 90 70 70 50 50 30 30

LVH (%)

New policy New policy RC RC

Multiply efforts for educating patients at carefully Multiply efforts for educating patients at carefully monitoring BP on a daily basis to aim at GLs monitoring BP on a daily basis to aim at GLs recommended systolic BP target (<140 mmHg). recommended systolic BP target (<140 mmHg). Systematic use of icodextrin in patients in Systematic use of icodextrin in patients in whom BP is insufficiently controlled or with whom BP is insufficiently controlled or with clinical evidence of volume expansion. clinical evidence of volume expansion.

slide-14
SLIDE 14

Clinical policies vary much across centres Clinical experience and background errors make a difference Peritoneal Dialysis Peritoneal Dialysis

Systolic BP Systolic BP mmHg mmHg 140 140 100 100 90 90 70 70 50 50 30 30

LVH (%)

New policy New policy RC RC

60% 60%

45 45 30 30 15 15 Systolic BP Systolic BP mmHg mmHg 140 140 100 100 90 90 70 70 50 50 30 30

LVH (%)

Centre Centre with less with less experience experience

57% 57%

Left atrium by the 10% larger

Different emphasis on volume Different emphasis on volume-

  • salt control may translate into

salt control may translate into

  • ccult volume overload in
  • ccult volume overload in

patients being treated in centres patients being treated in centres with less stringent salt with less stringent salt-

  • volume

volume policies. policies. Lung comets monitoring may be Lung comets monitoring may be useful to achieve salt useful to achieve salt-

  • volume

volume balance appropriate to individual balance appropriate to individual cardiac / hemodynamic profile cardiac / hemodynamic profile

slide-15
SLIDE 15

+ 2SD

  • 2SD

Average Concordance index=0.96, 95% CI: 0.90-0.98

Inter-observer agreement

60 40 20

  • 20
  • 40

[Lung comets (1st Obs)- Lung comets (2 nd Obs)]

200 150 100 50

[Lung comets (1st Obs)+ Lung comets (2nd Obs)]/2

Concordance index=0.98, 95% CI: 0.97-0.99

[Lung comets (3.5 MHz)+ Lung comets (3.0 MHz)]/2

100 80 60 40 20

[Lung comets (3.5 MHz) - Lung comets (3.0 MHz)]

15 10 5

  • 5
  • 10
  • 15

Agreement between probes / machines

Lung US is a reliable technique for the measurement

  • f

pulmonary water in dialysis patients.

slide-16
SLIDE 16

Lung comets monitoring may be Lung comets monitoring may be useful to achieve salt useful to achieve salt-

  • volume

volume balance appropriate to individual balance appropriate to individual cardiac / hemodynamic profile cardiac / hemodynamic profile late eighties late eighties BIA bielectrical impedance analysis BIA bielectrical impedance analysis enthusiasm enthusiasm disappointement disappointement controversy controversy Lung US still to be appropriately Lung US still to be appropriately tested tested : :

  • Cohort studies

Cohort studies

  • Clinical trials

Clinical trials

slide-17
SLIDE 17

Multicenter cohort study Multicenter cohort study 22 22 Nephrology and Dialysis Centers Nephrology and Dialysis Centers Enrollment started in April 2009 Enrollment started in April 2009

March 2011: 458 patients March 2011: 458 patients

slide-18
SLIDE 18

Modestly affected by adjustment for Framingham Risk factors and NYHA class

These preliminary analyses indicate that validating lung comets in a clinical trial would be worthwhile undertaking

Multicentric study N° 458 pts on dialysis Follow-up 400 days

Source

Cumulative risk of combined outcomes (%)

Combined outcome death, heart failure, anginal episodes, MI (initial analyses based on 63 events)

600 400 200 .3 .2 .1 0.0

Lung Comets <15 Lung Comets >45

HR: 3.03,

(95% CI: 1.58-5.81)

Lung Comets 16-45

slide-19
SLIDE 19

10 leading research groups in Italy, France, 10 leading research groups in Italy, France, Germany, GB, Sweden, Spain, Poland, Greece, Germany, GB, Sweden, Spain, Poland, Greece, Romania, Turkey Romania, Turkey

slide-20
SLIDE 20

S S &

& C

C

La congestione cardiopolmonare La congestione cardiopolmonare è è comune nei pazienti in dialisi e nella comune nei pazienti in dialisi e nella maggioranza dei casi maggioranza dei casi è è pauci o asintomatica. pauci o asintomatica. La semplice misura dei volumi liquidi non offre informazion La semplice misura dei volumi liquidi non offre informazioni rilevanti per i rilevanti per indirizzare le decisioni cliniche nei pazienti in dialisi. indirizzare le decisioni cliniche nei pazienti in dialisi. La misura dell La misura dell

  • acqua polmonare con gli US

acqua polmonare con gli US è è una tecnica promettente in una tecnica promettente in quanto fornisce informazioni affidabili sul grado di congestio quanto fornisce informazioni affidabili sul grado di congestione polmonare, ne polmonare, cio cioè è su un fenomeno da prevenire o correggere tempestivamente nei su un fenomeno da prevenire o correggere tempestivamente nei pazienti in dialisi. pazienti in dialisi. L L

  • utilit

utilità à di questa tecnica deve essere testata in uno specifico tri di questa tecnica deve essere testata in uno specifico trial al clinico. clinico.

slide-21
SLIDE 21

10% 10% coronary heart disease

coronary heart disease Heart failure Heart failure

13% 13%

Cerebrovascular Cerebrovascular disease disease

7% 7%

MORTALITY IN ESRD

non non-

  • cardiovascular

cardiovascular

Sudden Death Sudden Death 20% 20%

slide-22
SLIDE 22

LC <15 LC 16-45 LC >45

1.0 0.9 0.8 0.7 800 700 600 500 400 300 200 100

Time (days)

Cumulative events free survival

Combined outcome death, heart failure, anginal episodes, MI

HR: 3.03,

(95% CI: 1.58-5.81)

slide-23
SLIDE 23

Pulmonary Pressure Pulmonary Pressure (mmHg) (mmHg)

Left atrial Volume Left atrial Volume

r=0.33, P=0.002 r=0.32, P=0.006

70 60 50 40 30 20 10 200 150 100 50

Lung comets (n)

r=0.39, P<0.001 r=0.30, P=0.01

30 25 20 15 10 5

(mL/m2.7)

200 150 100 50

Lung comets (n)

r=-0.73, P<0.001 r=-0.64, P<0.001

80 70 60 50 40 30 20 10 200 150 100 50

Lung comets (n)

Detection of pulmonary congestion by chest ultrasound (US) in dialysis patients. Mallamaci F, Benedetto A, Tripepi R, Rastelli S, Castellino P, Tripepi G, Picano E, Zoccali C 3:586 ; 2010

LV Ejection LV Ejection Fraction (%) Fraction (%)

slide-24
SLIDE 24

Extracellular Volume (sodium space) Extracellular Volume (sodium space)

LV filling Pressure LV filling Pressure

8 8-

  • 10 mmHg

10 mmHg

Externally, intermittently Externally, intermittently regulated ECV regulated ECV

Like in other conditions, LV filling Like in other conditions, LV filling pressure in ESRD reflects the pressure in ESRD reflects the loading conditions

  • f

the left loading conditions

  • f

the left ventricle, i.e. a fundamental factor ventricle, i.e. a fundamental factor for central hemodynamics for central hemodynamics

kidney is central in regulating the kidney is central in regulating the blood volume blood volume

  • LV filling pressure

LV filling pressure relationship relationship

slide-25
SLIDE 25

5 yr Survival 5 yr Survival % % <35 35 <35 35-

  • 44 45

44 45-

  • 54 55

54 55-

  • 64 >64

64 >64 Age at start of dialysis Age at start of dialysis (years)

(years)

100 100 80 80 60 60 40 40 20 20

Tassin

EDTA

USRDS

  • Clinical policies adopted in

Clinical policies adopted in Tassin make a difference Tassin make a difference . .

slide-26
SLIDE 26

All cause mortality All cause mortality HR HR

1.5 1.5 1.4 1.4 1.3 1.3 1.2 1.2 1.1 1.1 1.0 1.0 0.8 0.8

0.5-1.0 1.0-1.5 1.5-2.0 2.5-3.0 3.0-3.5 3.5-4.0 >4.0 Kg. 2.0-2.5

High body weight gain, High body weight gain, Better appetite and nutrition status! Better appetite and nutrition status! Adjusted for malnutrition/inflammation Adjusted for malnutrition/inflammation

slide-27
SLIDE 27

% % 100 100 10 10 1 1 0.1 0.1 0.01 0.01 25 25-

  • 34 45

34 45-

  • 54 65

54 65-

  • 74 >85

74 >85 Age (years Age (years)

)

General population General population

Dialysis patients USRDS Dialysis patients USRDS

X X 500

500

X X 5

5

Annual mortality for CV diseases Annual mortality for CV diseases